biosimilar
- noun
- /ˌbaɪoʊˈsɪmɪlər/
- Specialized
- Recent studies have shown that biosimilars can be just as effective as their reference biologics in treating diseases.
- approve biosimilars
- biosimilar company
- develop biosimilars
Examples
-
I think it's reasonable that we ask Teva et al. to show their biosimilar is not an inferior or more dangerous product.
Blog text (28) -
The 16th ICDRA, hosted by Brazil in 2014, dedicated a separate meeting to regulating similar biotherapeutic products (or biosimilars), issuing useful recommendations to countries and WHO.
Academic text (2016) -
We have agencies that would test the viability of any potential biosimilar.
Blog text (28) -
The whole biosimilars thing is a tricky business.
Blog text (28) -
The arguments being made by Jane and others, namely that biosimilars are similar enough, are based on faith, not science.
Blog text (28) -
We agree that biosimilars should be regulated for safety and efficacy.
Blog text (28) -
The issue with Eshoo's legislation isn't with the definition of biosimilar, and regulatory control assuring that these medicines really are similar is not a problem.
Blog text (28) -
No one is saying that biosimilars shouldn't be assayed and analyzed to assure they are the same as the reference medication.
Blog text (28) -
This evolution should move attention from mature products towards priority essential medicines that pose special challenges to regulators, such as human insulin and other biosimilars, and newly developed essential medicines.
Academic text (2016) -
The introduction of biosimilars has the potential to lower the costs of biologic treatments for patients.
Synonyms
A medicine made from living cells or proteins to treat disease
A medicine made from living cells or biological processes
Surface Forms
Morphology
biosimilar = biosimilar (semi-transparent) = bio + similar
This noun is a converted use of the adjective biosimilar, and the technical meaning is only partly predictable from the component parts.
Etymology
A biosimilar comes from bio- 'life' and similar 'like', the same parts you see in biology, which helps show that a biosimilar drug is a biological medicine very like an approved one and works the same for patients.